Relief Therapeutics Holding AG (RLFTF)

[Dash82]

Dr. J said a long time ago that patients in the inhaled trial would use a portable nebulizer at home. It’s well known that majority of people who use inhalers to treat asthma use the inhaler incorrectly. Nebulizers are much more effective at getting medicine into the lungs. Given that it’s already outpatient, and the serious consequences of the progression of Covid19, I don’t see why they would move to inhaler. There has also been no indication from Relief or NeuroRX that they will, but who knows. I don’t think it changes anything one way or the other tbh.